Abstract
The initial rollout of COVID-19 vaccines has been challenged by logistical issues, limited availability of doses, scarce healthcare capacity, spotty acceptance, and variants of concern. Non-pharmaceutical interventions (NPIs) have been critical to support these phases. At the same time, the arrival of vaccines might have changed the risk assessment of some leading to a behavioural relaxation of NPIs. Several epidemic models have investigated the potential effects of this phenomenon on the COVID-19 pandemic, but they have not been validated against data. Recent empirical evidence, obtained via surveys, provides conflicting results on the matter. Hence, the extent behavioural relaxation induced by COVID-19 vaccines is still far from clear. Here, we aim to study this phenomenon in four regions. To this end, we implement five realistic epidemic models which include age structure, multiple virus strains, NPIs, and vaccinations. One of the models acts as a baseline, while the other four extend it and, building on the literature, include different behavioural relaxation mechanisms. First, we set the stage by calibrating the baseline model and running counterfactual scenarios to quantify the impact of vaccinations and NPIs. Our results confirm the critical role of both in reducing infection and mortality rates. Second, we calibrate the four behavioural models to real data and compare them to each other and to the baseline. While behavioural models offer a better fit of weekly deaths in all regions, this improvement is offset by their increased complexity in three locations. In the region where one of the behavioural model emerges as the most likely, our findings suggest that relaxation of NPIs led to a relative increase of deaths of more than 8%, highlighting the potential negative effect of this phenomenon. Overall, our work contributes to the retrospective validation of epidemic models developed amid the COVID-19 Pandemic.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
Y.L. acknowledges support from the China Scholarship Council (CSC). N.G. acknowledges support from the Lagrange Project of the Institute for Scientific Interchange Foundation (ISI Foundation) funded by Fondazione Cassa di Risparmio di Torino (Fondazione CRT)
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Yes
Footnotes
↵* n.perra{at}qmul.ac.uk
Data Availability
All data produced are available online at https://github.com/Jadecoool/Estimating-behavioural-relaxation-induced-by-COVID-19-vaccines-in-the-first-months-of-their-rollout/tree/main
